Krsnaa Diagnostics Limited has informed the Exchange about General Updates
KRSNAA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Krsnaa Diagnostics' Board has approved the re-appointment of Mr. Rajendra Mutha (DIN: 01066737) as Whole-time Director and Chairman, redesignated as Executive Chairman, for a further 5-year term from April 26, 2026 to April 25, 2031. The decision, based on the Nomination and Remuneration Committee's recommendation, is subject to shareholder approval via postal ballot. Mr. Mutha, a certified pharmacist with over two decades of experience in pharmacy and diagnostics, currently serves as the company's Chairman and leads its CSR and community health initiatives. The disclosure confirms he is not debarred by SEBI and is not related to any other director on the board.
This is a continuity announcement with no change in leadership direction. Existing shareholders should expect stable strategic guidance, and the re-appointment is unlikely to materially move the stock price. Postal ballot approval from shareholders will be the next procedural step.